Skip to main content
Big pharma and social responsibility.
Ageing and multiple sclerosis.
"Is this new medicine going to help me walk again?"
Silent symptoms of multiple sclerosis.
The multiple sclerosis gut microbiota: A systematic review.
Grassroot efforts towards diversity in MS care and research: Win-win for patients and science.
Multiple sclerosis and migration revisited.
A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Three suggestions to decrease the financial burden of MS treatments.